Article
Safety of the 9-Valent Human Papillomavirus Vaccine
Tom T. Shimabukuro, John R. Su, Paige L. Marquez, Adamma Mba-Jonas, Jorge E. Arana and Maria V. Cano
Pediatrics December 2019, 144 (6) e20191791; DOI: https://doi.org/10.1542/peds.2019-1791
Tom T. Shimabukuro
Division of Healthcare Quality Promotion, Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; and
John R. Su
Division of Healthcare Quality Promotion, Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; and
Paige L. Marquez
Division of Healthcare Quality Promotion, Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; and
Adamma Mba-Jonas
Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland
Jorge E. Arana
Division of Healthcare Quality Promotion, Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; and
Maria V. Cano
Division of Healthcare Quality Promotion, Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; and

Data supplements
Data Supplement
In this issue
Safety of the 9-Valent Human Papillomavirus Vaccine
Tom T. Shimabukuro, John R. Su, Paige L. Marquez, Adamma Mba-Jonas, Jorge E. Arana, Maria V. Cano
Pediatrics Dec 2019, 144 (6) e20191791; DOI: 10.1542/peds.2019-1791
Jump to section
Related Articles
Cited By...
- No citing articles found.